Growth Metrics

Burning Rock Biotech (BNR) Consolidated Net Income: 2019-2024

Historic Consolidated Net Income for Burning Rock Biotech (BNR) over the last 6 years, with Dec 2024 value amounting to -$45.9 million.

  • Burning Rock Biotech's Consolidated Net Income fell 91.19% to $16.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.9 million, marking a year-over-year decrease of 106.92%. This contributed to the annual value of -$45.9 million for FY2024, which is 49.80% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Consolidated Net Income of -$45.9 million as of FY2024, which was up 49.80% from -$91.4 million recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's Consolidated Net Income registered a high of -$45.9 million during FY2024, and its lowest value of -$140.2 million during FY2022.
  • Moreover, its 3-year median value for Consolidated Net Income was -$91.4 million (2023), whereas its average is -$92.5 million.
  • Per our database at Business Quant, Burning Rock Biotech's Consolidated Net Income plummeted by 154.76% in 2020 and then soared by 49.80% in 2024.
  • Yearly analysis of 5 years shows Burning Rock Biotech's Consolidated Net Income stood at -$62.4 million in 2020, then tumbled by 99.86% to -$124.7 million in 2021, then fell by 12.43% to -$140.2 million in 2022, then skyrocketed by 34.83% to -$91.4 million in 2023, then skyrocketed by 49.80% to -$45.9 million in 2024.